“It’s a win-win – increased relevance for HCPs and greater impact for our business.”

“ekoDNA^® has brought about a paradigm shift in the way we approach planning and implementing omnichannel campaigns. Its intuitive, step-by-step setup process means we can now plan sophisticated customer-centric campaigns and rapidly get them to market, without having to rely on the timely support of other technical resources and internal stakeholders.

What sets ekoDNA^® apart is its proprietary HCP profiling. It captures rich insights on each HCP based on the data points we select. These insights allow ekoDNA^® to go beyond superficial grouping and truly understand each HCP’s interests. This enables the platform to deliver content tailored to each individual HCP, creating real personalization at scale.

The significant lift we saw in HCP engagement, clearly demonstrated the immense value of ekoDNA^®‘s personalized experiences in meeting HCP needs while aligning with our brand objectives. It’s a win-win – increased relevance for HCPs and greater impact for our business.

The actionable insights help the brand team continually optimize content and focus on high-value activities. I’m thrilled by how much more relevant and valuable our HCP interactions have become with ekoDNA^®.”

BETH FISHER
Commercial Manager
Established Products – Bayer plc
(November 2022)

“ekoDNA^® has been a game-changer for improving our customer experiences.”

“We were impressed with how quickly we were able to implement ekoDNA^®. We managed to complete the initial set-up process in a single workshop, configuring a robust multi-dimensional segmentation model that captured the depth of attitudes, beliefs, and behaviors of our target customers. Within days, we had an AI engine orchestrating highly relevant clinical content. We quickly saw the benefits in the form of measurable shifts in HCP beliefs and behaviors aligned to our communication objectives. The resulting insights into HCP needs and interests were invaluable for creating content that delivers more value. We saw engagement rates increase significantly thanks to ekoDNA^®‘s ability to match the right content to the right HCP profile.

Rolling out the model globally was simple, enabling our brand teams worldwide to benefit from this level of personalization. The end-to-end process is smooth and efficient.

ekoDNA^® has been a game-changer for improving our customer experiences. The combination of multi-dimensional segmentation, AI orchestration and actionable insights empowers us to have more rewarding conversations and drive engagement that supports HCPs’ complex clinical content needs.”

UWE ABERLE
Global Brand Lead
Established Products – Bayer AG
(June 2022)

“By incorporating industry-focused functions to optimize time and resources, ekoDNA^® enabled me to focus on content accuracy and compliance”

“As the Medical Lead responsible for reviewing and approving all content for our recent omnichannel HCP campaign, I was fascinated to find out how I would need to adapt my processes to review content orchestrated by artificial intelligence, as I had not experienced this before.

The integrated Veeva Vault PromoMats approval process enabled our team to seamlessly submit content for my review. Within a few days, I was able to fully review and approve the personalized campaign components. This was a straightforward process as the content was packaged in a format that enabled me to understand the context of its proposed use and any content-usage rules or dependencies.

I was reassured to find out that ekoDNA^® was developed specifically for the life sciences industry and this meant that the ekoDNA^®  team were able to provide supporting documentation illustrating how their platform operates within our strict regulatory framework.

By incorporating industry-focused functions to optimize time and resources, ekoDNA^® enabled me to focus on content accuracy and compliance rather than get bogged down in bureaucratic bottlenecks. I’m pleased that we now have a content orchestration solution that takes into consideration our responsibility to meet the regulatory standards required of the Life Sciences industry.”

PROFESSOR FARID SAAD
Global Medical Lead
Established Products – Bayer AG
(November 2022)

Ready to explore how ekoDNA^® can help you?

We believe these stories of success and innovation showcase the level of value we strive to deliver for every customer. We’re grateful these customers took the time to share their experiences and results achieved with ekoDNA^®.

If you’re considering how an integrated omnichannel personalization solution could benefit your organization, we hope these testimonials provide inspiration and confidence in what’s possible. We’d love for your company to become our next success story.